Posted on 12/11/17
Report: Hospitals Contribute $23.4 Billion to N.J. Economy
New Jersey hospitals and health systems contributed $23.4 billion to the Garden State economy in 2016, according to the 2017 N.J. Hospitals Economic Impact Report released . . .
Posted on 12/8/17
Will CVS Get the Chance to Buy Aetna?
In this Market Foolery podcast, host Chris Hill is joined by Industry Focus: Healthcare host, Kristine Harjes, to dig into CVS Health's (NYSE:CVS) offer to purchase . . .
Posted on 12/8/17
Merk 2018 Outlook
With the stock market and Bitcoin reaching all-time highs, what can possibly go wrong? In offering my thoughts on 2018, I see my role in reminding . . .
Posted on 12/8/17
Why 2017 Was a Year to Forget for Merck & Co. Inc.
Better luck next year. That's what Merck & Co. (NYSE:MRK) is hoping for after a disappointing 2017. Merck stock is down year to date by 7%, . . .
Posted on 12/8/17
Merck To Lay Off 58 Employees In Charlotte
Merck Sharpe & Dohme Corp., a subsidiary of Merck & Co., will close one of its Charlotte facilities, resulting in 58 lost jobs, according to a . . .
Posted on 12/8/17
Alexion and Halozyme Enter License Agreement for ENHANZE Technology
NEW HAVEN, Conn. & SAN DIEGO--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) and Halozyme Therapeutics, Inc. (NASDAQ:HALO) announced today a collaboration and license agreement that enables Alexion to . . .
Posted on 12/7/17
Marquis Health Services Announces Partnership with Reliant Rehabilitation
Marquis Health Services’ therapy gyms offer professional services and state-of-the-art equipment. At The Brentwood Rehabilitation and Healthcare Center in Danvers, Mass., the program includes a smart . . .
Posted on 12/6/17
Aetna (AET) Aetna Agrees To Be Acquired By CVS Conference (Transcript)
Aetna, Inc. (NYSE:AET)Aetna agrees to be acquired by CVS Conference CallDecember 04, 2017 08:30 AM ETExecutivesMike McGuire - SVP, IR, CVS HealthMark Bertolini - Chairman and . . .
Posted on 12/6/17
Tabula Rasa HealthCare Prices Sale of Shares of Common Stock
MOORESTOWN, N.J., Dec. 05, 2017 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), a healthcare technology company optimizing medication safety by deploying new medication risk mitigation . . .
Posted on 12/5/17
Medidata Expands Partnership with CytomX Therapeutics
NEW YORK--(BUSINESS WIRE)--Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that CytomX Therapeutics, Inc., a biopharmaceutical company . . .
Posted on 12/5/17
Will 2018 Be Johnson & Johnson's Best Year Yet?
There are still several weeks left in the year, but Johnson & Johnson (NYSE:JNJ) appears to be on course to generate its second-highest stock performance over . . .
Posted on 12/5/17
3 Reasons Pfizer Should Buy Celgene in 2018
You might think it's a crazy idea. Maybe it is a crazy idea. But sometimes crazy ideas are the ones that wind up being the best. . . .
Posted on 12/5/17
Tabula Rasa HealthCare Announces Proposed Offering of Common Stock
MOORESTOWN, N.J., Dec. 04, 2017 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) , a healthcare technology optimizing medication safety by deploying new medication risk mitigation . . .
Posted on 12/5/17
OncLive and The Ruesch Center Honored the 2017 Winners of the Luminary Awards in GI Cancers
CRANBURY, N.J.--(BUSINESS WIRE)--The inaugural Luminary Awards in GI Cancer, which was hosted by OncLive®andThe Ruesch Center for the Cure of Gastrointestinal Cancers on Friday, Dec 1., . . .
Posted on 12/5/17
Sunspire Health Launches New Website
LYNDHURST, N.J.--(BUSINESS WIRE)--Sunspire Health, a nationwide network of addiction treatment facilities offering personalized treatment and addiction recovery services across the United States, announced today the launch . . .
Posted on 12/4/17
Blue Oak and PsychoGenics Announce a Drug Discovery Partnership
BOSTON & PARAMUS, N.J.--(BUSINESS WIRE)--Blue Oak Pharmaceuticals, Inc. (Blue Oak) and PGI Drug Discovery LLC (PsychoGenics), today announced that they have entered into a partnership to . . .
Posted on 12/4/17
Axsome Therapeutics Announces $9.5 Million Registered Direct Offering Priced At-the-Market
NEW YORK, Dec. 01, 2017 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system . . .
Posted on 12/1/17
Better Buy: GlaxoSmithKline plc vs. Pfizer
Big drug companies can add an element of stability to investor portfolios. People get sick and need treatment whether the economy is booming or tanking. And . . .
Posted on 12/1/17
Will Johnson & Johnson Do a Stock Split in 2018?
Healthcare has been an exciting industry lately, and Johnson & Johnson (NYSE:JNJ) casts a wide net over the sector. The company not only sells well-known consumer . . .
Posted on 12/1/17
Better Buy: Ziopharm Oncology Inc. vs. Celldex Therapeutics, Inc.
The American Cancer Society expects 600,920 Americans to die from cancer this year, but Ziopharm Oncology Inc. (NASDAQ:ZIOP) and Celldex Therapeutics, Inc. (NASDAQ:CLDX) aim to lower . . .
Posted on 11/30/17
It's A Good Time To Buy Merck
Best Reward-to-Risk trade-off of the DJ-30 stocksThat accolade today goes to Merck & Co., Inc. (MRK).Figure 1(Used with permission)Upside price rewards come from the behavioral analysis . . .
Posted on 11/30/17
Recordati Rare Diseases Partners With the National Urea Cycle Disorders Foundation
Recordati Rare Diseases Inc., a biopharmaceutical company committed to providing orphan therapies to underserved rare disease communities in the U.S., today announced a new Check Ammonia . . .
Posted on 11/30/17
Cohen Children's Medical Center Launches Fundraising, Marketing Campaigns
Cohen Children's Medical Centertoday announced the launch of its first integrated fundraising campaign to help the nonprofit – recognized as one of the nation's best children's . . .
Posted on 11/30/17
Regeneron and Decibel Therapeutics Announce Strategic Collaboration
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Decibel Therapeutics, Inc., today announced a collaboration to discover and develop new potential therapeutics to protect, repair, and restore hearing.Decibel . . .
Posted on 11/29/17
iBio Announces Proposed Public Offering of Common Stock
NEW YORK, Nov. 28, 2017 (GLOBE NEWSWIRE) -- IBIO, INC. (NYSE AMERICAN:IBIO) announced today that it intends to launch an offering of shares of its common . . .

